IDNA ETF

IDNA ETF
$39.77
See how much of IDNA you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Returns Overview

1 Month
-3.89%
3 Months
+10.31%
6 Months
+13.75%
YTD
+23.71%
1 Year
+54.22%
3 Years (annualized)
+11.79%
5 Years (annualized)
-7.47%

Risk Metrics (1-Year)

No risk data available for this ETF

Stress Test Scenarios

How would IDNA have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
PROUpgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
PROUpgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
PROUpgrade to run

1 Month Performance

3 Months Performance

6 Months Performance

1 Year Performance

Benchmark & Peers

Benchmark
NYSE FactSet Global Genomics and Immuno Biopharma Index(^NYFSGIB)
This ETF (YTD)
+23.71%
Peer Avg (YTD)
+6.74%
vs Peers
+16.97%

IDNA ETF Performance

IDNA performance across multiple time periods: 1-month -3.89%, YTD 23.71%, 1-year 54.22%, 3-year 11.79%, 5-year -7.47%.

IDNA returns outperform the peer average of 6.74% YTD. With an expense ratio of 0.47%, investors should weigh costs against performance when evaluating this ETF.

IDNA vs another fund shows side-by-side returns. IDNA alternatives are available in the ETF Screener.

Compare IDNA

IDNA vs SPYIDNA vs QQQIDNA vs VOOIDNA vs VTIIDNA vs IVVIDNA vs SCHDIDNA vs VYMIDNA vs VXUS

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month-3.89%N/A
3 Months+10.31%N/A
6 Months+13.75%N/A
1 Year+54.22%N/A
3 Years+11.79%N/A
5 Years-7.47%N/A

Periods up to 1 year are total returns; 3, 5 and 10 year figures are annualized